Gene · 2114
Papers2,490
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,490
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring maternal-fetal interface with in vitro placental and trophoblastic models. | Front Cell Dev Biol | 2023 | 38033854 | PubTator, text mining | PubMed |
| Advances in Intercellular Communication Mediated by Exosomal ncRNAs in Cardiovascular Disease. | Int J Mol Sci | 2023 | 38003385 | PubTator, text mining | PubMed |
| Genome-wide identification and characteristic analysis of ETS gene family in blood clam Tegillarca granosa. | BMC Genomics | 2023 | 37990147 | PubTator, text mining | PubMed |
| SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer. | Nat Commun | 2023 | 37973913 | PubTator, text mining | PubMed |
| Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target. | Cancers (Basel) | 2023 | 37958417 | PubTator, text mining | PubMed |
| Exploring the pathogenesis of osteomyelitis accompanied by diabetic foot ulcers using microarray data analysis. | Medicine (Baltimore) | 2023 | 37904457 | PubTator, text mining | PubMed |
| Pathogenesis and therapeutic implications of EBV-associated epithelial cancers. | Front Oncol | 2023 | 37901329 | PubTator, text mining | PubMed |
| Single-cell transcriptomics uncover hub genes and cell-cell crosstalk in patients with hypertensive nephropathy. | Int Immunopharmacol | 2023 | 37897949 | PubTator, text mining | PubMed |
| Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids. | Pharmaceutics | 2023 | 37896275 | PubTator, text mining | PubMed |
| USP39-Mediated Non-Proteolytic Control of ETS2 Suppresses Nuclear Localization and Activity. | Biomolecules | 2023 | 37892157 | PubTator, text mining | PubMed |
| Differential gene expression of immunity and inflammation genes in colorectal cancer using targeted RNA sequencing. | Front Oncol | 2023 | 37869102 | PubTator, text mining | PubMed |
| Correlation of the methylomic signature of smoking during pregnancy with clinical traits in ADHD. | J Psychiatry Neurosci | 2023 | 37857414 | PubTator, text mining | PubMed |
| Single-cell characterization of self-renewing primary trophoblast organoids as modeling of EVT differentiation and interactions with decidual natural killer cells. | BMC Genomics | 2023 | 37853336 | PubTator, text mining | PubMed |
| Challenging Tumor Heterogeneity with HER2, p16 and Somatostatin Receptor 2 Expression in a Case of EBV-Associated Lymphoepithelial Carcinoma of the Salivary Gland. | Head Neck Pathol | 2023 | 37847488 | PubTator, text mining | PubMed |
| Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer. | Front Immunol | 2023 | 37828981 | PubTator, text mining | PubMed |
| Exosome, the glass slipper for Cinderella of cancer-bladder cancer? | J Nanobiotechnology | 2023 | 37805491 | PubTator, text mining | PubMed |
| IL-33 priming and antigenic stimulation synergistically promote the transcription of proinflammatory cytokine and chemokine genes in human skin mast cells. | BMC Genomics | 2023 | 37798647 | PubTator, text mining | PubMed |
| ERK1-mediated immunomodulation of mesenchymal stem cells ameliorates inflammatory disorders. | iScience | 2023 | 37790278 | PubTator, text mining | PubMed |
| Personalized clinical managements through exploring circulating neural cells and electroencephalography. | World J Exp Med | 2023 | 37767542 | PubTator, text mining | PubMed |
| Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer. | Biologics | 2023 | 37767463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2114/papers?page=8